000028 國藥一致
按盤價 
25.380 +0.110 (+0.435%)
25.380 +0.110 (+0.435%) | 2025/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 36,796,598 | -2.62% | 74,378,494 | 75,477,485 | 73,443,137 | 68,357,810 | |
| 減：營業總成本 | 35,955,919 | -2.88% | 73,017,475 | 73,277,097 | 71,309,688 | 66,519,747 | |
| 其中:營業成本 | 32,864,812 | -2.31% | 66,129,209 | 66,425,426 | 64,516,926 | 60,339,298 | |
| 財務費用 | 83,179 | -30.91% | 239,424 | 204,535 | 189,514 | 212,483 | |
| 資產減值損失 | (4,695) | -51.80% | (994,532) | (17,577) | (71,588) | (242,905) | |
| 公允價值變動收益 | -- | -- | (20,675) | (15,161) | 28,871 | -- | |
| 投資收益 | 136,126 | -28.38% | 241,793 | 237,029 | 139,131 | 292,381 | |
| 其中：對聯營企業和合營企業的投資收益 | 179,971 | -20.81% | 369,703 | 315,446 | 298,527 | 333,397 | |
| 營業利潤 | 926,496 | -2.36% | 573,478 | 2,467,425 | 2,306,069 | 1,952,411 | |
| 利潤總額 | 918,113 | -4.16% | 575,469 | 2,473,227 | 2,311,070 | 1,974,853 | |
| 減：所得稅費用 | 205,519 | 9.37% | 338,466 | 514,739 | 539,332 | 447,211 | |
| 淨利潤 | 712,594 | -7.46% | 237,004 | 1,958,487 | 1,771,738 | 1,527,642 | |
| 減：非控股權益 | 46,686 | 75.73% | (405,490) | 359,231 | 285,030 | 191,214 | |
| 股東淨利潤 | 665,907 | -10.43% | 642,493 | 1,599,256 | 1,486,708 | 1,336,428 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.200 | -10.45% | 1.150 | 2.870 | 2.670 | 3.120 | |
| 每股派息 (元) * | -- | -- | 0.366 | 0.680 | 0.800 | 0.600 | |
| 每股淨資產 (元) * | 32.586 | 2.00% | 31.747 | 31.290 | 37.666 | 34.861 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 10/10/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
